Skip to main content
Catherine Broome, MD, Hematology, Washington, DC, MedStar Georgetown University Hospital

CatherineMBroomeMD

Hematology • Washington, DC

Clotting Disorder, Hemophilia & Bleeding Disorder

Associate Professor, Medicine, Georgetown University School of Medicine

Request Appointment

Overview of Dr. Broome

Dr. Catherine Broome is a hematologist in Washington, DC and is affiliated with MedStar Georgetown University Hospital. She received her medical degree from LSU School of Medicine in Shreveport and has been in practice 32 years. Dr. Broome accepts several types of health insurance, listed below. She is one of 14 doctors at MedStar Georgetown University Hospital who specialize in Hematology. She has more than 20 publications and over 500 citings.

Clinical Expertise

  • Hematologic oncology, Autoimmune hemolytic anemia, Complement deficiencies, Immune thrombocytopenic purpura, Hemolytic-uremic syndrome, Bleeding disorders, Anemia

Education & Training

  • George Washington University
    George Washington UniversityFellowship, Hematology and Medical Oncology, 1988 - 1991
  • Prisma Health/University of South Carolina SOM Greenville (Greenville)
    Prisma Health/University of South Carolina SOM Greenville (Greenville)Residency, Internal Medicine, 1985 - 1988
  • LSU School of Medicine in Shreveport
    LSU School of Medicine in ShreveportClass of 1985

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 1989 - 2024
  • VA State Medical License
    VA State Medical License 1993 - 2022
  • MD State Medical License
    MD State Medical License 2010 - 2020
  • SC State Medical License
    SC State Medical License 1986 - 1993
  • LA State Medical License
    LA State Medical License 1985 - 1989
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013

Publications & Presentations

PubMed

Abstracts/Posters

  • Fostamatinib, a Spleen Tyrosine Kinase (SYK) Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (wAIHA): Final Results of the Phase 2, Multicent...
    Catherine M. Broome, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • Researchers Find Drug Effective to Treat Autoimmune Blood Disorder
    Researchers Find Drug Effective to Treat Autoimmune Blood DisorderDecember 12th, 2022
  • After One Week, Efgartigimod Helps 38% of ITP Patients Achieve Platelet Counts to Avoid Bleeding
    After One Week, Efgartigimod Helps 38% of ITP Patients Achieve Platelet Counts to Avoid BleedingDecember 11th, 2022
  • Drug Found to Be Effective in Difficult to Treat Autoimmune Blood Disorder
    Drug Found to Be Effective in Difficult to Treat Autoimmune Blood DisorderDecember 10th, 2022
  • Join now to see all

Professional Memberships

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    Anthem KeyCare PPO
    BCBS Blue Card PPO
    BCBS California PPO
    CareFirst BlueChoice Advantage
    CareFirst BlueChoice Network POS
    CareFirst BluePreferred PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    First Health PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Dr. Catherine Broome, Dr. Catherine Broome, MD, Dr. C Broome, Dr. Catherine M Broome